Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (51-60 of 197) with videos related to

Pageof 20
Sort By:
BMC Neuroscience|March 11, 2025
Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathiesEdward Rockenstein, Kiren Ubhi, Michael Mante, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 17, 2012
Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloidYaomin Chen, Xiumei Huang, Yun-wu Zhang, et al.
The American Journal of Pathology|March 26, 2011
Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with RoscovitineChristina Patrick, Leslie Crews, Paula Desplats, et al.
The Journal of Biological Chemistry|July 20, 2005
High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer diseaseEdward Rockenstein, Michael Mante, Michael Alford, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 23, 2007
Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylationEdward Rockenstein, Magdalena Torrance, Anthony Adame, et al.
Neurobiology of Disease|December 24, 2013
Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophyChristine L Kragh, Amanda M Gysbers, Edward Rockenstein, et al.
Journal of Neuropathology and Experimental Neurology|December 8, 2004
Human wild-type alpha-synuclein impairs neurogenesisBeate Winner, D Chichung Lie, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 22, 2004
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synucleinSheila M Fleming, Jonathan Salcedo, Pierre-Olivier Fernagut, et al.
Molecular Neurodegeneration|September 28, 2011
Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disordersLeslie Crews, Rebecca Ruf, Christina Patrick, et al.
Molecular Neurodegeneration|September 29, 2012
Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson's diseasePaula Desplats, Pruthul Patel, Kori Kosberg, et al.
Pageof 20

Showing results (51-60 of 197) with videos related to

Sort By:
Pageof 20
BMC Neuroscience|March 11, 2025
Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathiesEdward Rockenstein, Kiren Ubhi, Michael Mante, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 17, 2012
Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloidYaomin Chen, Xiumei Huang, Yun-wu Zhang, et al.
The American Journal of Pathology|March 26, 2011
Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with RoscovitineChristina Patrick, Leslie Crews, Paula Desplats, et al.
The Journal of Biological Chemistry|July 20, 2005
High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer diseaseEdward Rockenstein, Michael Mante, Michael Alford, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 23, 2007
Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylationEdward Rockenstein, Magdalena Torrance, Anthony Adame, et al.
Neurobiology of Disease|December 24, 2013
Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophyChristine L Kragh, Amanda M Gysbers, Edward Rockenstein, et al.
Journal of Neuropathology and Experimental Neurology|December 8, 2004
Human wild-type alpha-synuclein impairs neurogenesisBeate Winner, D Chichung Lie, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 22, 2004
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synucleinSheila M Fleming, Jonathan Salcedo, Pierre-Olivier Fernagut, et al.
Molecular Neurodegeneration|September 28, 2011
Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disordersLeslie Crews, Rebecca Ruf, Christina Patrick, et al.
Molecular Neurodegeneration|September 29, 2012
Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson's diseasePaula Desplats, Pruthul Patel, Kori Kosberg, et al.
Pageof 20